Tuberc Respir Dis.  2018 Jan;81(1):88-90. 10.4046/trd.2017.0116.

Is Osteoporosis a Common Comorbidity in Different Chronic Airway Diseases?

• Lee SH

• KMID: 2420595
• DOI: http://doi.org/10.4046/trd.2017.0116

Abstract

No abstract available.

MeSH Terms

Comorbidity*
Osteoporosis*

Reference

1. Smolonska J, Koppelman GH, Wijmenga C, Vonk JM, Zanen P, Bruinenberg M, et al. Common genes underlying asthma and COPD? Genome-wide analysis on the Dutch hypothesis. Eur Respir J. 2014; 44:860–872.

2. Pleasants RA, Ohar JA, Croft JB, Liu Y, Kraft M, Mannino DM, et al. Chronic obstructive pulmonary disease and asthma-patient characteristics and health impairment. COPD. 2014; 11:256–266.

3. Rhee CK, Yoon HK, Yoo KH, Kim YS, Lee SW, Park YB, et al. Medical utilization and cost in patients with overlap syndrome of chronic obstructive pulmonary disease and asthma. COPD. 2014; 11:163–170.

4. Sin DD. Asthma-COPD overlap syndrome: what we know and what we don't. Tuberc Respir Dis. 2017; 80:11–20.

5. GOLD 2017 Global strategy for the diagnosis, management and prevention of COPD [Internet]. Gaithersberg: Global Initiative for Chronic Obstructive Lung Disease;2017. cited 2017 Nov 11. Available from: http://goldcopd.org/gold-2017-global-strategy-diagnosis-management-preventioncopd/.

6. Alshabanat A, Zafari Z, Albanyan O, Dairi M, FitzGerald JM. Asthma and COPD overlap syndrome (ACOS): a systematic review and meta analysis. PLoS One. 2015; 10:e0136065.

7. Liang B, Feng Y. The association of low bone mineral density with systemic inflammation in clinically stable COPD. Endocrine. 2012; 42:190–195.

8. Kang HK, Kim K, Lee H, Jeong BH, Koh WJ, Park HY. COPD assessment test score and serum C-reactive protein levels in stable COPD patients. Int J Chron Obstruct Pulmon Dis. 2016; 11:3137–3143.

9. Kauppi P, Kupiainen H, Lindqvist A, Tammilehto L, Kilpelainen M, Kinnula VL, et al. Overlap syndrome of asthma and COPD predicts low quality of life. J Asthma. 2011; 48:279–285.

10. Weatherall M, Travers J, Shirtcliffe PM, Marsh SE, Williams MV, Nowitz MR, et al. Distinct clinical phenotypes of airways disease defined by cluster analysis. Eur Respir J. 2009; 34:812–818.

11. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax. 2009; 64:728–735.

12. Almagro P, Cabrera FJ, Diez J, Boixeda R, Alonso Ortiz MB, Murio C, et al. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest. 2012; 142:1126–1133.

13. Oh JY, Lee YS, Min KH, Lee SY, Shim JJ, Kang KH, et al. Osteoporosis in patients with asthma-chronic obstructive pulmonary disease overlap syndrome. Tuberc Respir Dis. 2018; 81:73–79.

14. van Boven JF, Roman-Rodriguez M, Palmer JF, Toledo-Pons N, Cosio BG, Soriano JB. Comorbidome, pattern, and impact of asthma-COPD overlap syndrome in real lfe. Chest. 2016; 149:1011–1020.

15. Halpern MT, Schmier JK, Van Kerkhove MD, Watkins M, Kalberg CJ. Impact of long-term inhaled corticosteroid therapy on bone mineral density: results of a meta-analysis. Ann Allergy Asthma Immunol. 2004; 92:201–207.

16. Jones A, Fay JK, Burr M, Stone M, Hood K, Roberts G. Inhaled corticosteroid effects on bone metabolism in asthma and mild chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2002; (1):CD003537.

17. Liu SF, Kuo HC, Liu GH, Ho SC, Chang HC, Huang HT, et al. Inhaled corticosteroids can reduce osteoporosis in female patients with COPD. Int J Chron Obstruct Pulmon Dis. 2016; 11:1607–1614.

18. Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2004; 170:760–765.

19. Ozol D, Aysan T, Solak ZA, Mogulkoc N, Veral A, Sebik F. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients. Respir Med. 2005; 99:1494–1500.

20. Omoigui S. The Interleukin-6 inflammation pathway from cholesterol to aging: role of statins, bisphosphonates and plant polyphenols in aging and age-related diseases. Immun Ageing. 2007; 4:1.

21. Kiyokawa H, Muro S, Oguma T, Sato S, Tanabe N, Takahashi T, et al. Impact of COPD exacerbations on osteoporosis assessed by chest CT scan. COPD. 2012; 9:235–242.

22. Barnes PJ. Therapeutic approaches to asthma-chronic obstructive pulmonary disease overlap syndromes. J Allergy Clin Immunol. 2015; 136:531–545.

23. Gauderman WJ, Urman R, Avol E, Berhane K, McConnell R, Rappaport E, et al. Association of improved air quality with lung development in children. N Engl J Med. 2015; 372:905–913.